Prospects for the future of prostate cancer vaccines

被引:8
作者
Madan, Ravi A. [1 ]
Gulley, James L. [1 ]
机构
[1] NCI, Genitourinary Malignancies Branch, Bethesda, MD 20892 USA
关键词
combination therapy; therapeutic cancer vaccines; Vaccines; immune combinations; prostate cancer; CASTRATION; IMMUNOTHERAPY; ABIRATERONE; ANTAGONIST; IPILIMUMAB; THERAPY; CELLS; MEN;
D O I
10.1586/14760584.2015.1118348
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cancer therapy is undergoing a revolution fueled by clinical data demonstrating that the immune system has significant anti-tumor capability. Although the main focus of this revolution currently rests upon immune checkpoint inhibitors in diseases such as melanoma, lung and bladder cancer, it was actually a therapeutic cancer vaccine in prostate cancer that provided the first data demonstrating that a modern immunotherapy, beyond cytokines, could enhance clinical outcomes. As immunotherapy is poised to take center stage among cancer therapies, the role of cancer vaccines remains somewhat undefined in prostate cancer, though emerging data suggest that vaccines could play a crucial therapeutic role.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 20 条
[1]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[2]   Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model [J].
Ardiani, Andressa ;
Farsaci, Benedetto ;
Rogers, Connie J. ;
Protter, Andy ;
Guo, Zhimin ;
King, Thomas H. ;
Apelian, David ;
Hodge, James W. .
CLINICAL CANCER RESEARCH, 2013, 19 (22) :6205-6218
[3]  
Chi N, 2014, INT J CLIN EXP MED, V7, P3181
[4]   Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen [J].
Drake, CG ;
Doody, ADH ;
Mihalyo, MA ;
Huang, CT ;
Kelleher, E ;
Ravi, S ;
Hipkiss, EL ;
Flies, DB ;
Kennedy, EP ;
Long, MX ;
McGary, PW ;
Coryell, L ;
Nelson, WG ;
Pardoll, DM ;
Adler, AJ .
CANCER CELL, 2005, 7 (03) :239-249
[5]   Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer [J].
Fong, Lawrence ;
Carroll, Peter ;
Weinberg, Vivian ;
Chan, Stephen ;
Lewis, Jera ;
Corman, John ;
Amling, Christopher L. ;
Stephenson, Robert A. ;
Simko, Jeffrey ;
Sheikh, Nadeem A. ;
Sims, Robert B. ;
Frohlich, Mark W. ;
Small, Eric J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11)
[6]   Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors [J].
Fu, Juan ;
Malm, Ian-James ;
Kadayakkara, Deepak K. ;
Levitsky, Hy ;
Pardoll, Drew ;
Kim, Young J. .
CANCER RESEARCH, 2014, 74 (15) :4042-4052
[7]   Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities [J].
Garnett-Benson, Charlie ;
Hodge, James W. ;
Gameiro, Sofia R. .
SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (01) :46-53
[8]   Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer [J].
Gulley, James L. ;
Heery, Christopher R. ;
Madan, Ravi A. ;
Walter, Beatriz A. ;
Merino, Maria J. ;
Dahut, William L. ;
Tsang, Kwong-Yok ;
Schlom, Jeffrey ;
Pinto, Peter A. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (09) :1521-1531
[9]   Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer [J].
Gulley, JL ;
Arlen, PM ;
Bastian, A ;
Morin, S ;
Marte, J ;
Beetham, P ;
Tsang, KY ;
Yokokawa, J ;
Hodge, JW ;
Ménard, C ;
Camphausen, K ;
Coleman, CN ;
Sullivan, F ;
Steinberg, SM ;
Schlom, J ;
Dahut, W .
CLINICAL CANCER RESEARCH, 2005, 11 (09) :3353-3362
[10]   Effects of castration on thymocyte development in two different models of thymic involution [J].
Heng, TSP ;
Goldberg, GL ;
Gray, DHD ;
Sutherland, JS ;
Chidgey, AP ;
Boyd, RL .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :2982-2993